Navigation Links
CET Life Sciences Center Welcomes Belmont University School of Pharmacy as New Tenant
Date:7/1/2008

Lab to promote collaborative ventures between Belmont's School of Pharmacy

and health care providers

NASHVILLE, Tenn., July 1 /PRNewswire/ -- Cumberland Emerging Technologies, Inc. (CET) today announced that Belmont University has established the Belmont School of Pharmacy Department of Pharmaceutical Sciences Laboratory at the CET Life Sciences Center. The Life Sciences Center, which is located in downtown Nashville, provides lab and office space, equipment and infrastructure to early-stage biopharmaceutical ventures.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080701/CLTU108 )

Belmont has leased the space to support research and service programs of its School of Pharmacy. The primary objective of the lab is to provide dosage form development, characterization and quality analysis. The school will work with the pharmaceutical industry and local and regional health care providers to meet previously unmet and emerging needs related to drug delivery.

The work being performed at the Life Sciences Center is designed to help provide drug delivery solutions, which is unique to pharmacy practice and which, until now, has not played a major role in middle Tennessee's robust health care scene," said Dr. Andrew Webster, Chair and Professor of Pharmaceutical Sciences at Belmont's School of Pharmacy. "By partnering with CET, our faculty and students have access to a community of resources to advance research that will help drug developers bring their products to patients who need them most."

"We are delighted to welcome Belmont School of Pharmacy to our growing roster of tenants at the Life Sciences Center," said A.J. Kazimi, Chief Executive Officer of Cumberland Pharmaceuticals and CET. "Partnering with outstanding academic research and training programs like this one is a key component of CET's strategy, and we look forward to pr
'/>"/>

SOURCE Cumberland Emerging Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
5. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
6. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
7. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
8. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
9. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
10. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
11. The Pittsburgh Life Sciences Greenhouse Adds New Companies to its Investment Portfolio

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...Nov. 9 "Micro cap and small cap eq... more broker sponsorship and exposure as a ,buying... in commodity-driven stocks like gold, silver and ...he Haft Group, Inc, Manhattan based investor relat...cap equities market in the US and Canada, and with...
(Date:11/9/2009)...LBERG, Austria, November 9 For mor...e been working on the development of a,Brain-Compu...n channel,between the brain and a computer. Such a...ommunicate or to control devices in their environm... some patients have been supervised by,the researc...
(Date:11/9/2009)...., Nov. 9 CEL-SCI Corpor...Kenneth S. Rosenthal, Professor of Immunology and ...lege of Medicine and Pharmacy, reported on work co...eveland Clinic and CEL-SCI on CEL-SCI,s LEAPS vacc... GTCbio Vaccine: "All Things Considered" Conferenc...
(Date:11/9/2009)..., November 9 Following the provisi...and Drug Administration (FDA), privately,owned UK ...avalinternational.com ) has been informed that its... been awarded an Orphan-Drug,designation for the t...,, ALS, also known as Lou Gehrig,s disease,...
Breaking Biology Technology:Haft Group says Bullish Commodity Market Triggers Small and Micro-cap Upsurge 2intendiX - Communication by Thoughts: First Patient-Ready System on the Market 2CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 2CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 3
...et Revenues - $33.9 million vs. $24.0 million in Q...41.5%, Q3 2008 Diluted Net Income per Share - $0... increase of 85.7% Q3 2008 Operating Inco...New Bookings of $43.0 million vs. $35.5 million in...ogy,Inc. (eRT), (Nasdaq: ERES ), a leading provid...
..., Mass., Oct. 30 Idenix,Pharmaceuticals, Inc. (Na...,in the discovery and development of drugs for the...eases, today reported unaudited financial results,...ber 30, 2008. At,September 30, 2008, Idenix,s cash...ed approximately $60.1 million., 2008 Year-to-Dat...
..., N.J., Oct. 30 Medarex, Inc.,(Nasdaq: MEDX ) an...r ended,September 30, 2008., Medarex,s net loss f...million, or ($0.36) per share, as compared to a ne...the third quarter of 2007. Included in the 2008,re...0.04) per share, for,stock based compensation reco...
Other Biology Technology:eResearchTechnology Reports Third Quarter 2008 Results 2eResearchTechnology Reports Third Quarter 2008 Results 3eResearchTechnology Reports Third Quarter 2008 Results 4eResearchTechnology Reports Third Quarter 2008 Results 5eResearchTechnology Reports Third Quarter 2008 Results 6eResearchTechnology Reports Third Quarter 2008 Results 7eResearchTechnology Reports Third Quarter 2008 Results 8eResearchTechnology Reports Third Quarter 2008 Results 9eResearchTechnology Reports Third Quarter 2008 Results 10Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results 2Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results 3Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results 4Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results 5Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results 6Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results 7Medarex Announces 2008 Third Quarter Financial Results 2Medarex Announces 2008 Third Quarter Financial Results 3Medarex Announces 2008 Third Quarter Financial Results 4Medarex Announces 2008 Third Quarter Financial Results 5Medarex Announces 2008 Third Quarter Financial Results 6Medarex Announces 2008 Third Quarter Financial Results 7Medarex Announces 2008 Third Quarter Financial Results 8Medarex Announces 2008 Third Quarter Financial Results 9
(Date:11/6/2009)...versary this month of the publication of On the Or...cal Sciences (AIBS) is publishing open access two ...s historic insights into evolution. , The two art...ifornia, Berkeley, and James T. Costa of Western C...bout Charles Darwin," appeared in the October issu...
(Date:11/6/2009)...wire/ -- Auburn Hills, MI-based Law Enforcement In...ts locker system and patent-pending Biometric Acce...t of Health and Human Services, National Institute...er system will support the NIH,s entire police for... medical research agency. The project is expected...
(Date:11/5/2009)... Biology Teachers (NABT) will recognize Leonard C....ugatuck Valley Community College (NVCC) in Waterbu... Award during the NABT annual professional develop...Denver, Colorado. , The Evolution Education Awar...ogical Sciences,(AIBS) and Biological Sciences Cu...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2Conference Hound Launches Dedicated Conference and Trade Show Search Engine 52405 1Conference Hound Launches Dedicated Conference and Trade Show Search Engine 52405 2Texas Health Dallas Receives Double Honor From American Heart Association 52401 1Texas Health Dallas Receives Double Honor From American Heart Association 52401 2Service Corporation International Announces Schedule For Its Second Quarter 2009 Earnings Release and Conference Call 52397 1Service Corporation International Announces Schedule For Its Second Quarter 2009 Earnings Release and Conference Call 52397 2
...e University Medical Center and at the National In...ave shown how broken sections of chromosomes can r... , "People have discovered high levels of repeat... and spun theories about why there are so many rep...ar in Duke,s Department of Molecular Genetics and ...
...a nano scale how can you see what you have made? ...nces research Council (BBSRC) fellow has made a si...nge faced by nanotechnology scientists. With new ...em, the team from the University of Liverpool, Th...e University of Leeds, show that they have develop...
...f biological processes; it is an active participan...s in which the actions of the solvent play a key r...lding processes has been on observation of the pro... by Martin Gruebele and Martina Havenith have now ...twork during protein folding in real time. As they...
Other Biology News:Duke-NIEHS team shows how DNA repairs may reshape the genome 2Scientists overcome nanotech hurdle 2Scientists overcome nanotech hurdle 3Keeping an eye on the surroundings 2
AGAROSE PREP, 50G from GE Healthcare, formerly Amersham Biosciences
Amino Acid Mixture Minus Leucine from Promega
...strains are K-12 derivatives that have mutations i...hione reductase (gor) genes, which greatly enhance...es have shown that expression in Origami(DE3) yiel...st even though overall expression levels were simi...
...0 (YELLOW), 1 EA. Ultrospec 6300 pro UV/Visible ...ents of the Pharmacopoeia in terms of instrument s...nefits of being able to be used for rapid, discret...t scanning capability., *Press to read high perfor...
Biology Products: